Stewart Susan B. 4
4 · Candel Therapeutics, Inc. · Filed Apr 12, 2022
Insider Transaction Report
Form 4
Stewart Susan B.
Chief Regulatory Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-11+20,000→ 20,000 totalExercise: $5.12Exp: 2032-04-11→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on May 11, 2022, subject to the Reporting Person's continued service on each such vesting date.